These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 32215658)
1. Something old, something new: a paradigm for considering immune therapies for cardiovascular disease. Weber BN; Blankstein R Cardiovasc Res; 2020 Apr; 116(5):e51-e53. PubMed ID: 32215658 [No Abstract] [Full Text] [Related]
2. Colchicine for the treatment of cardiovascular diseases: old drug, new targets. Andreis A; Imazio M; De Ferrari GM J Cardiovasc Med (Hagerstown); 2021 Jan; 22(1):1-8. PubMed ID: 32858634 [TBL] [Abstract][Full Text] [Related]
3. Colchicine in coronary disease: another renaissance of an ancient drug. Fiolet ATL; Thompson PL; Mosterd A Cardiovasc Res; 2021 Jan; 117(1):e4-e6. PubMed ID: 33426561 [No Abstract] [Full Text] [Related]
4. Colchicine Use in Acute Coronary Syndromes: An Update. Tapoi L; Benchea L; Siriopol D; Kanbay M; Covic A Angiology; 2021 Jul; 72(6):503-510. PubMed ID: 33412929 [TBL] [Abstract][Full Text] [Related]
6. Old Drugs for New Indications in Cardiovascular Medicine. Arbel Y; Abuzeid W; Rosenson RS; Weisman A; Farkouh ME Cardiovasc Drugs Ther; 2018 Apr; 32(2):223-232. PubMed ID: 29633048 [TBL] [Abstract][Full Text] [Related]
7. Colchicine for prevention of cardiovascular events. Hemkens LG; Ewald H; Gloy VL; Arpagaus A; Olu KK; Nidorf M; Glinz D; Nordmann AJ; Briel M Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD011047. PubMed ID: 26816301 [TBL] [Abstract][Full Text] [Related]
8. The Role of Suppressing Inflammation in the Treatment of Atherosclerotic Cardiovascular Disease. Roman YM; Hernandez AV; White CM Ann Pharmacother; 2020 Oct; 54(10):1021-1029. PubMed ID: 32425120 [TBL] [Abstract][Full Text] [Related]
9. Colchicine in Patients With Coronary Artery Disease: A Systematic Review and Meta-Analysis of Randomized Trials. Kofler T; Kurmann R; Lehnick D; Cioffi GM; Chandran S; Attinger-Toller A; Toggweiler S; Kobza R; Moccetti F; Cuculi F; Jolly SS; Bossard M J Am Heart Assoc; 2021 Aug; 10(16):e021198. PubMed ID: 34369166 [TBL] [Abstract][Full Text] [Related]
10. Cardiovascular Risk in Rheumatoid Arthritis and Mechanistic Links: From Pathophysiology to Treatment. Fragoulis GE; Panayotidis I; Nikiphorou E Curr Vasc Pharmacol; 2020; 18(5):431-446. PubMed ID: 31258091 [TBL] [Abstract][Full Text] [Related]
11. Cytokines as therapeutic targets for cardio- and cerebrovascular diseases. Liberale L; Ministrini S; Carbone F; Camici GG; Montecucco F Basic Res Cardiol; 2021 Mar; 116(1):23. PubMed ID: 33770265 [TBL] [Abstract][Full Text] [Related]
14. Colchicine in Coronary Artery Disease: An Old Acquaintance in New Attire? Giannopoulos G; Angelidis C; Papoutsidakis N; Panagopoulou V; Cleman MW; Lekakis J; Deftereos S Curr Med Chem; 2015; 22(36):4177-88. PubMed ID: 26467282 [TBL] [Abstract][Full Text] [Related]
15. Inflammation May be the Future of Cardiovascular Risk Reduction: Does Colchicine have a Current Indication? Whayne TF Am J Cardiovasc Drugs; 2021 Jan; 21(1):1-10. PubMed ID: 32356107 [TBL] [Abstract][Full Text] [Related]
16. [Anti-inflammatory therapy in cardiovascular disease; from hypothesis to future guideline?]. Hoogeveen RM; Stroes ESG; Cornel JH Ned Tijdschr Geneeskd; 2020 Oct; 164():. PubMed ID: 33201620 [TBL] [Abstract][Full Text] [Related]
17. Why the CANTOS Is a Game Changer in Cardiovascular Medicine. Abbate A J Cardiovasc Pharmacol; 2017 Dec; 70(6):353-355. PubMed ID: 29216016 [No Abstract] [Full Text] [Related]
18. Effects of colchicine on major adverse cardiac events in next 6-month period after acute coronary syndrome occurrence; a randomized placebo-control trial. Akrami M; Izadpanah P; Bazrafshan M; Hatamipour U; Nouraein N; Drissi HB; Manafi A BMC Cardiovasc Disord; 2021 Dec; 21(1):583. PubMed ID: 34876021 [TBL] [Abstract][Full Text] [Related]